Shanghai Fudan Forward S&T Co., Ltd (SHA:600624)

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007	Dec 31, 2006	Dec 31, 2005
Financial Insurance System Software	196.38M
Financial Insurance System Software Growth	0.99%
Digestive System Medicines	141.42M
Digestive System Medicines Growth	-20.36%
Drugs for the Nervous System	80.59M
Drugs for the Nervous System Growth	-1.32%
Other Medicines	23.05M
Other Medicines Growth	-6.50%
Circulatory System Drugs	21.10M
Circulatory System Drugs Growth	-31.22%
Anti-tumor Drugs	18.66M
Anti-tumor Drugs Growth	54.21%
Immune Function Regulating Drugs	15.71M
Immune Function Regulating Drugs Growth	2.17%
Other Business	12.67M
Other Business Growth	-2.39%
Fuhua Park Haimen Garden Supporting Residential Project (Fuhua Wenyuan)	2.93M
Fuhua Park Haimen Garden Supporting Residential Project (Fuhua Wenyuan) Growth	33.19%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007	Dec 31, 2006	Dec 31, 2005
China	372.54M
China Growth	-10.58%
Overseas	272.78M
Overseas Growth	3.69%